Medfield Diagnostics AB logo

MEDF TR - Medfield Diagnostics AB Share Price

SEK0.001 0.0  0.0%

Last Trade - 07/01/19

Sector
Healthcare
Size
Micro Cap
Market Cap £8.86m
Enterprise Value £7.35m
Revenue £69.3k
Position in Universe th / 1733
Bullish
Bearish
Unlock MEDF TR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MEDF TR Revenue Unlock MEDF TR Revenue

Net Income

MEDF TR Net Income Unlock MEDF TR Revenue

Normalised EPS

MEDF TR Normalised EPS Unlock MEDF TR Revenue

PE Ratio Range

MEDF TR PE Ratio Range Unlock MEDF TR Revenue

Dividend Yield Range

MEDF TR Dividend Yield Range Unlock MEDF TR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MEDF TR EPS Forecasts Unlock MEDF TR Revenue
Profile Summary

Medfield Diagnostics AB is a Sweden-based developer of medical instrumentation. The Company develops, markets and sells diagnostic instrumentation based on microwave technology. The Company's microwave technology complements other imaging principles in two main ways. Firstly microwaves sense dielectric properties and provide high contrast for biological matter with different water content, thus enabling diagnosis of for example blood in brain tissue or tumors in breast tissue. Secondly microwave instruments are compact and thus used earlier in the healthcare chain, in emergency rooms and in ambulances. The Company’s products include R10; the M100, available on stroke services for night-time surveillance of patients at increased risk of stroke, as well as D1000 that is a diagnostic instrument for use in emergency rooms and ambulances to diagnose the type of stroke, ischemic (blood clot) or hemorrhagic (bleeding).

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Public Since May 2, 2012
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 25,655,356
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MEDF TR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to MEDF TR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.